Labomar acquires a majority stake in Laboratorios Entema and enters Spanish market - Cleon Capital

Labomar acquires a majority stake in Laboratorios Entema, expanding into the Spanish market. Located near Barcelona, Laboratorios Entema is a leading CDMO in functional cosmetics. Labomar’s CEO, Walter Bertin, highlights the strategic importance of this acquisition for gaining access to the Spanish nutraceutical market and enhancing their functional cosmetics expertise.

Cleon Capital played a key role in closing this deal, providing crucial technical support alongside Charterhouse Capital Partners. This acquisition follows Labomar’s recent M&A activity, including Sphera Encapsulation, reinforcing their growth trajectory in the nutraceutical sector.